Persistent fetal vasculature

Editor-In-Chief: Prab R Tumpati, MD
Obesity, Sleep & Internal medicine
Founder, WikiMD Wellnesspedia &
W8MD's weight loss doctor NYC
Philadelphia GLP-1 weight loss and GLP-1 clinic NYC
| Persistent fetal vasculature | |
|---|---|
| Synonyms | Persistent hyperplastic primary vitreous (PHPV) |
| Pronounce | N/A |
| Specialty | N/A |
| Symptoms | Leukocoria, strabismus, nystagmus, microphthalmia |
| Complications | Cataract, glaucoma, retinal detachment |
| Onset | Congenital |
| Duration | Lifelong |
| Types | N/A |
| Causes | Failure of the fetal hyaloid vascular system to regress |
| Risks | Premature birth, intrauterine growth restriction |
| Diagnosis | Ophthalmoscopy, ultrasound, MRI |
| Differential diagnosis | Retinoblastoma, Coats' disease, retinopathy of prematurity |
| Prevention | N/A |
| Treatment | Surgery, vitrectomy, cataract extraction |
| Medication | N/A |
| Prognosis | Variable, depends on severity and treatment |
| Frequency | Rare |
| Deaths | N/A |
Persistent fetal vasculature (PFV), also known as persistent hyperplastic primary vitreous (PHPV), is a congenital developmental anomaly of the eye. It occurs when the fetal hyaloid vascular system, which normally regresses before birth, fails to involute. This condition can lead to various ocular abnormalities and visual impairment.
Pathophysiology[edit]
During normal fetal development, the hyaloid artery supplies blood to the developing lens and vitreous body. This artery typically regresses and disappears before birth. In PFV, this regression does not occur, leading to the persistence of the hyaloid artery and its associated structures. The persistent vasculature can cause traction on the retina, leading to retinal detachment, and can also result in cataract formation, microphthalmia, and other structural abnormalities.
Clinical Presentation[edit]
PFV can present in various forms, ranging from mild to severe. Common clinical features include:
- Leukocoria (white pupillary reflex)
- Strabismus (misalignment of the eyes)
- Nystagmus (involuntary eye movement)
- Microphthalmia (abnormally small eye)
- Cataract (clouding of the lens)
- Glaucoma (increased intraocular pressure)
Diagnosis[edit]
Diagnosis of PFV is primarily clinical, based on the characteristic appearance of the eye. Imaging studies such as ultrasound, computed tomography (CT), and magnetic resonance imaging (MRI) can be used to confirm the diagnosis and assess the extent of the anomaly. Ophthalmoscopy and fundus photography are also useful in visualizing the persistent vasculature and associated retinal changes.
Treatment[edit]
The treatment of PFV depends on the severity of the condition and the associated ocular abnormalities. Options include:
- Surgical intervention to remove the persistent vasculature and address associated complications such as cataracts and retinal detachment.
- Laser therapy to ablate the persistent vessels.
- Medical management for associated conditions like glaucoma.
Early intervention is crucial to prevent further visual impairment and to optimize visual outcomes.
Prognosis[edit]
The prognosis for PFV varies depending on the severity of the condition and the success of treatment. Early detection and appropriate management can improve visual outcomes, but severe cases may result in significant visual impairment or blindness.
See also[edit]
Template:Congenital malformations and deformations of eye, ear, face, and neck
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
- Medical weight loss NYC
- Affordable GLP-1 injections NYC
- Budget GLP-1 weight loss shots Philadelphia
- New Jersey medical weight loss
- NYC medical weight loss blog
- Philadelphia weight loss blog
- Sleep medicine and sleep apnea services
- W8MD MedSpa and wellness
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian